Takeda Pharmaceutical Company Limited Net Foreign Exchange Loss
Takeda Pharmaceutical Company Limited (TKPHF) reported Net Foreign Exchange Loss of JPY 7.21 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2025-06-25
| Period end | Net Foreign Exchange Loss 12 month |
|---|---|
| 2025-03-31 | 7.21B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 44.66B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 14.21B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 1.79B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 97.32B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 0.00 JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 10.28B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 0.00 JPY 20-F · filed 2019-06-27 |